Angela Harmantas is a senior financial journalist with Proactive Investors. She has nearly ten years' experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government. She currently resides in Toronto.
Shares rose more than 11% after news that LeanLife’s proprietary Omega-3 product will be distributed to a consumer base of some of the continent’s largest food producers
The Vancouver-based company developed a patented process to isolate Omega-3 fatty acids from flax seeds that can be used as food additives or nutraceuticals
The company's flagship drug CaPre is being developed to treat severe hypertriglyceridemia, a metabolic condition that contributes to increased risk of cardiovascular disease and pancreatitis
The specialty pharmaceutical company will seek to repurchase approximately 6.8% of outstanding Medexus stock and around 10% of its public float, or a total of 1,005,333 shares
The revenue increase was driven by Crescita’s licencee, Taro Pharmaceuticals, reaching a contractual sales milestone as Pliaglis sales soared in the United States
The health sciences company received a judgement against JCN Capital Corp
In March, the Canadian cannabis producer closed a $2.4 billion investment from Marlboro cigarette maker Altria Inc